Mehmet Akif Buyukbese
Scientific Tracks Abstracts: J Diabetes Metab
Despite tremendous efforts by both healthcare professionals and social organizations, diabetes keep increasing, providing an enormous burden of healthcare cost in developing and developed countries. Since the establishment of Turkey Republic in 1923, the official study published is not more than a decade ago under the supervision of WHO (Turkish Diabetes Epidemiology Project-TURDEP I). Surprising rate of diabetes increase (94%) found in TURDEP II, which was announced two years ago indicated an extra-effort is needed for convincing people with diabetes, encouraging them for attending to modern diabetes management discipline.
Mehmet Akif Buyukbese has an MD degree from Istanbul University, Istanbul Faculty of Medicine and has completed internal medicine residency program at Cerrahpasa Faculty of Medicine, Istanbul, Turkey in 1999 where he started focusing on diabetes subject. He founded internal medicine department at KSU Medical School in 2000 and served as a head for 6 years. Board certified in internal medicine (2002, Turkey)He had several diabetes management and research observership experiences in the US such as Albert Einstein College of Medicine, University of Yeshiva, Bronx, NY (2 months), MD Anderson, Univ TX Houston Diabetes and Endocrinology Program (3 months) and Indian Medical Health Center, NIH, Diabetes Outpatient Clinic (Phoenix), worked as a postdoctoral research fellow in UK (Univ of Leicester, Clinical Diabetes Research Centre-5 months), Kronos Longevity Research Institute, Phoenix, AZ (1.5 years-2009). Has an ECFMG certificate (2008). He is member of IDF, Trustees of Turkish Diabetes Foundation, European Society of Cardiology. Served for Southeastearn Anatolia Diabetes Project for 6 years and now he is the Kahramanmaras City Coordinator of ?Presidency of Turkey Diabetes-Peer? Project. He has been appointed full professorship in 2011 and carrying on his diabetes patient and family medicine physician eduaction programs as well as phase 3 and phase 4 diabetes drug clinical studies in the same university. He has more than a 100 publications both in Turkish and English in internal medicine area mostly in diabetes. He is in the editorial board of Open Inflammatory Journal, Journal of Clinical Medicine and Research and reviewer of Science Alert, European Journal of Internal Medicine, Balkan Medical Journal, Diabetes Forum (Turkish), Diabetes Science and Endocrinology (Turkish), Glance at Diabetes (Turkish), Turkey Clinics Medical Science, Dialogue in Endocrinology (Turkish)., etc
